| |
| |
|
| Insider
Information: |
Winger Dennis L |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
288,465 |
|
|
Indirect Shares
|
11,500 |
|
|
| Direct
Value |
$3,385,161 |
|
|
|
Indirect Value
|
$2,606,280 |
|
|
| Total
Shares |
299,965 |
|
|
| Total
Value |
$5,991,441 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Applera-Applied Biosys |
ABI |
Senior Vice President ... |
2008-11-21 |
0 |
2003-07-11 |
0 |
Premium* |
|
|
Heron Therapeutics Inc |
HRTX |
Director |
2006-08-11 |
69,544 |
2003-07-25 |
0 |
Premium* |
|
|
Vertex Pharmaceuticals Inc |
VRTX |
Director |
2012-03-09 |
6,500 |
2010-02-16 |
6,500 |
Premium* |
|
|
Accuray Inc |
ARAY |
Director |
2017-11-30 |
162,181 |
2010-11-30 |
0 |
Premium* |
|
|
Nektar Therapeutics |
NKTR |
Director |
2018-08-21 |
42,750 |
2018-08-21 |
5,000 |
Premium* |
|
|
Pacira Pharmaceuticals, Inc. |
PCRX |
Director |
2017-06-14 |
7,490 |
2014-12-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2018-08-21 |
4 |
S |
$60.30 |
$904,500 |
D/D |
(15,000) |
42,750 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2018-08-21 |
4 |
OE |
$14.26 |
$213,900 |
D/D |
15,000 |
57,750 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2018-08-17 |
4 |
S |
$59.62 |
$894,300 |
D/D |
(15,000) |
42,750 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2018-08-17 |
4 |
OE |
$14.26 |
$213,900 |
D/D |
15,000 |
57,750 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2018-08-14 |
4 |
S |
$60.15 |
$1,030,069 |
D/D |
(17,125) |
42,750 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2018-08-13 |
4 |
S |
$61.04 |
$1,045,310 |
D/D |
(17,125) |
59,875 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2018-01-04 |
4 |
OE |
$11.97 |
$403,988 |
D/D |
33,750 |
77,000 |
0 |
- |
|
| ARAY |
Accuray Inc |
Director |
– • – |
2017-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
29,126 |
162,181 |
0 |
- |
|
| ARAY |
Accuray Inc |
Director |
– • – |
2017-11-17 |
4 |
D |
$4.80 |
$45,624 |
D/D |
(9,505) |
133,055 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2017-09-19 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
43,250 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2017-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
1,357 |
7,490 |
0 |
- |
|
| ARAY |
Accuray Inc |
Director |
– • – |
2016-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
23,762 |
142,560 |
0 |
- |
|
| ARAY |
Accuray Inc |
Director |
– • – |
2016-11-21 |
4 |
D |
$5.30 |
$36,135 |
D/D |
(6,818) |
118,798 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2016-09-21 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
34,250 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2016-09-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,000 |
26,250 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2016-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,488 |
6,133 |
0 |
- |
|
| ARAY |
Accuray Inc |
Director |
– • – |
2015-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
17,045 |
125,616 |
0 |
- |
|
| ARAY |
Accuray Inc |
Director |
– • – |
2015-11-20 |
4 |
D |
$6.80 |
$47,376 |
D/D |
(6,967) |
108,571 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2015-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
4,645 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2014-12-05 |
4 |
B |
$94.54 |
$250,058 |
D/D |
2,645 |
2,645 |
2.39 |
- |
|
| ARAY |
Accuray Inc |
Director |
– • – |
2014-12-01 |
4 |
D |
$6.65 |
$40,000 |
D/D |
(6,015) |
115,538 |
0 |
- |
|
| ARAY |
Accuray Inc |
Director |
– • – |
2014-11-28 |
4 |
A |
$0.00 |
$0 |
D/D |
17,416 |
121,553 |
0 |
- |
|
| ARAY |
Accuray Inc |
Director |
– • – |
2013-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
15,037 |
104,137 |
0 |
- |
|
| ARAY |
Accuray Inc |
Director |
– • – |
2013-03-05 |
4 |
B |
$4.30 |
$85,938 |
D/D |
20,000 |
89,100 |
2.39 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2012-12-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
11,250 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
